<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Clinical Policies &amp; Guidelines on Intracav Wiki</title>
    <link>http://localhost:54936/policies/</link>
    <description>Recent content in Clinical Policies &amp; Guidelines on Intracav Wiki</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 16 Oct 2024 13:16:02 -0500</lastBuildDate>
    <atom:link href="http://localhost:54936/policies/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Blood Draws and Hemolysis</title>
      <link>http://localhost:54936/policies/blood-draws-and-hemolysis/</link>
      <pubDate>Wed, 16 Oct 2024 13:16:02 -0500</pubDate>
      <guid>http://localhost:54936/policies/blood-draws-and-hemolysis/</guid>
      <description>&lt;h1 id=&#34;deep-dive-blood-draws-and-hemolysis&#34;&gt;Deep Dive Blood Draws and Hemolysis&lt;/h1&gt;
&lt;p&gt;Follow along Intracav Chat and interact with it yourself with &lt;a href=&#34;https://www.intracav.ai/chat?chatId=n934mw6jvnxddlevmiiesrxs&#34;&gt;this link&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;CVR (Catheter to Vein Ratio). The Optimal ratio is &amp;lt;45%.&lt;/p&gt;
&lt;h2 id=&#34;the-physics-and-math&#34;&gt;The Physics and Math&lt;/h2&gt;
&lt;p&gt;Alright, let&amp;rsquo;s talk about hemolysis but in this piece we’ll focus the context on blood draws, lab draws, blood samples, and lab samples. There’s a lot of contradicting anecdotes and confusion around which is the best device or technique to use. So let&amp;rsquo;s deep dive into the physics and biochemistry for this one. LET&amp;rsquo;S GOOO!!! First we’ll dive into the physics and then we’ll go into the biochemistry specifically around the red blood cells.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Cortisol Levels in Hospital Staff and Work Efficiency: A Critical Clinical Analysis</title>
      <link>http://localhost:54936/policies/cortisol-levels-in-hospital-staff-and-work-efficiency-a-critical-clinical-analysis/</link>
      <pubDate>Sat, 01 Jun 2024 13:16:02 -0500</pubDate>
      <guid>http://localhost:54936/policies/cortisol-levels-in-hospital-staff-and-work-efficiency-a-critical-clinical-analysis/</guid>
      <description>&lt;h1 id=&#34;cortisol-levels-in-hospital-staff-and-work-efficiency-a-critical-clinical-analysis&#34;&gt;Cortisol Levels in Hospital Staff and Work Efficiency: A Critical Clinical Analysis&lt;/h1&gt;
&lt;h2 id=&#34;executive-summary-the-hidden-crisis-in-healthcare-excellence&#34;&gt;Executive Summary: The Hidden Crisis in Healthcare Excellence&lt;/h2&gt;
&lt;p&gt;We&amp;rsquo;re confronting an invisible enemy in our hospitals—one that silently undermines clinical performance, compromises patient safety, and devastates our healthcare workforce. Cortisol dysregulation among hospital staff isn&amp;rsquo;t just a wellness concern; it&amp;rsquo;s a critical threat to medical excellence that demands immediate, evidence-based intervention.&lt;/p&gt;
&lt;p&gt;Cortisol, our body&amp;rsquo;s primary stress hormone, serves as both protector and destroyer in healthcare environments. While essential for acute stress response and maintaining physiological homeostasis, chronic elevation creates a cascade of devastating effects that directly impact clinical decision-making, patient care quality, and healthcare system sustainability.&lt;/p&gt;</description>
    </item>
    <item>
      <title>ASEPTIC NON-TOUCH TECHNIQUE (ANTT®) in Clinical Practice</title>
      <link>http://localhost:54936/policies/antt/</link>
      <pubDate>Sun, 21 Apr 2024 13:16:02 -0500</pubDate>
      <guid>http://localhost:54936/policies/antt/</guid>
      <description>&lt;h1 id=&#34;introduction&#34;&gt;Introduction&lt;/h1&gt;
&lt;p&gt;The ASEPTIC NON-TOUCH TECHNIQUE (ANTT®) is a pivotal approach in infection control during invasive clinical procedures and management of indwelling medical devices. Through an exploration of key definitions, practical applications, evidence-based recommendations, quality improvement strategies, and the significance of ANTT as a fundamental clinical competency, we aim to provide a thorough understanding of ANTT for healthcare practitioners. Drawing insights from the Infusion Nurses Society (INS) 9th Edition 2024 guidelines and scholarly sources, this paper serves as a comprehensive resource to advance the knowledge and implementation of ANTT in diverse healthcare environments.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Intracav AI Prompting Guidelines</title>
      <link>http://localhost:54936/policies/prompting-guidelines/</link>
      <pubDate>Thu, 21 Mar 2024 13:16:02 -0500</pubDate>
      <guid>http://localhost:54936/policies/prompting-guidelines/</guid>
      <description>&lt;h1 id=&#34;maximizing-your-experience-with-intracav-ai-a-comprehensive-guide&#34;&gt;Maximizing Your Experience with Intracav AI: A Comprehensive Guide&lt;/h1&gt;
&lt;p&gt;Welcome to Intracav AI, your dedicated assistant in the field of vascular access. To ensure you derive the maximum benefit from your interactions with me, let&amp;rsquo;s jump into some guidelines and recommendations on how to effectively utilize the capabilities of Intracav AI. By following these comprehensive guidelines, you can optimize your experience and leverage the full potential of this AI assistant to enhance your clinical practice, research initiatives, and overall proficiency in vascular access care.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Exploring the Dynamics of Clinical Decision Making in Vascular Access</title>
      <link>http://localhost:54936/policies/exploring-the-dynamics-of-clinical-decision-making-in-vascular-access/</link>
      <pubDate>Sat, 16 Mar 2024 13:16:02 -0500</pubDate>
      <guid>http://localhost:54936/policies/exploring-the-dynamics-of-clinical-decision-making-in-vascular-access/</guid>
      <description>&lt;h1 id=&#34;exploring-the-dynamics-of-clinical-decision-making-in-vascular-access-empowering-healthcare-providers&#34;&gt;&lt;strong&gt;Exploring the Dynamics of Clinical Decision Making in Vascular Access: Empowering Healthcare Providers&lt;/strong&gt;&lt;/h1&gt;
&lt;p&gt;In the intricate tapestry of healthcare, the domain of vascular access serves as a critical juncture where clinical decision-making plays a pivotal role. We aim to explore the nuances of clinical decision-making within vascular access, shedding light on the multifaceted aspects that guide healthcare providers in making informed choices for optimal patient care.&lt;/p&gt;
&lt;h2 id=&#34;understanding-clinical-decision-making-in-vascular-access&#34;&gt;&lt;strong&gt;Understanding Clinical Decision Making in Vascular Access&lt;/strong&gt;&lt;/h2&gt;
&lt;p&gt;Vascular access has seen interprofessional collaboration emerge as a fundamental pillar that underpins the delivery of safe and effective patient care. Infusion and vascular access services thrive on the synergy of healthcare professionals working together to meet the diverse needs of patients while aligning with organizational objectives. Specialist teams dedicated to vascular access play a crucial role in mitigating healthcare-acquired complications linked to central vascular access devices (CVADs) and in preventing catheter-associated bloodstream infections (CABSI). By adhering to jurisdictional regulations, these teams ensure the provision of high-quality infusion therapy and vascular access services.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Optimizing Vascular Device Removal</title>
      <link>http://localhost:54936/policies/optimizing-vascular-device-removal/</link>
      <pubDate>Sat, 16 Mar 2024 12:48:59 -0500</pubDate>
      <guid>http://localhost:54936/policies/optimizing-vascular-device-removal/</guid>
      <description>&lt;h1 id=&#34;optimizing-vascular-access-device-removal-evidence-based-strategies-and-recommendations&#34;&gt;Optimizing Vascular Access Device Removal: Evidence-Based Strategies and Recommendations&lt;/h1&gt;
&lt;p&gt;Within vascular access, the removal of devices plays a critical role in patient care, necessitating adherence to evidence-based protocols to mitigate risks and ensure optimal outcomes. Drawing upon reputable guidelines and research findings, let&amp;rsquo;s explore the best practices and recommendations for removing various vascular access devices.&lt;/p&gt;
&lt;h3 id=&#34;peripheral-intravenous-catheters-pivcs-and-midline-catheters&#34;&gt;Peripheral Intravenous Catheters (PIVCs) and Midline Catheters:&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;The INS 9th Edition 2024 guidelines underscore the importance of assessing the necessity of PIVCs and midline catheters regularly.&lt;/li&gt;
&lt;li&gt;Removal criteria include discontinuation from the treatment plan, unused status for 24 hours or more, and consideration of systemic complications.&lt;/li&gt;
&lt;li&gt;Swift removal of catheters inserted under suboptimal aseptic conditions is recommended to prevent infections and complications.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;nontunneled-central-vascular-access-devices-cvads-and-piccs&#34;&gt;Nontunneled Central Vascular Access Devices (CVADs) and PICCs:&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Daily assessment of the continued need for nontunneled CVADs and PICCs is advised, aligning with best practices outlined in the INS guidelines.&lt;/li&gt;
&lt;li&gt;Collaborative decision-making with the healthcare team is crucial for timely removal when devices are no longer essential for treatment.&lt;/li&gt;
&lt;li&gt;Precautions, such as preventing air embolism and avoiding forceful removal, are essential to minimize complications during CVAD removal.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;surgically-placed-cvads---tunneled-cuffed-catheters-and-implanted-ports&#34;&gt;Surgically Placed CVADs - Tunneled, Cuffed Catheters, and Implanted Ports:&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Regular evaluation of tunneled cuffed catheters and implanted ports is recommended to ensure appropriateness and functionality.&lt;/li&gt;
&lt;li&gt;Removal protocols should be initiated upon completion of infusion therapy or when devices are no longer integral to the care plan.&lt;/li&gt;
&lt;li&gt;Immediate reporting and management of any complications, such as cuff or port exposure, are imperative to prevent adverse events.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;These evidence-based strategies emphasize the significance of systematic assessment, collaborative decision-making, and adherence to established guidelines to optimize vascular access device removal and enhance patient safety.&lt;/p&gt;</description>
    </item>
    <item>
      <title>PAD</title>
      <link>http://localhost:54936/policies/pad/</link>
      <pubDate>Sat, 16 Mar 2024 12:47:43 -0500</pubDate>
      <guid>http://localhost:54936/policies/pad/</guid>
      <description>&lt;h1 id=&#34;peripheral-arterial-disease-pad-a-comprehensive-overview&#34;&gt;&lt;strong&gt;Peripheral Arterial Disease (PAD): A Comprehensive Overview&lt;/strong&gt;&lt;/h1&gt;
&lt;p&gt;Peripheral Arterial Disease (PAD) is a condition that affects the arteries outside the heart and brain, primarily caused by atherosclerosis, leading to reduced blood flow to the limbs. Understanding PAD is crucial for effective management and treatment strategies. Here are some key points extracted from various vascular access guidelines and textbooks, including the Infusion Nurses Society (INS) 9th Edition 2024:&lt;/p&gt;
&lt;h2 id=&#34;glossary-insights&#34;&gt;&lt;strong&gt;Glossary Insights:&lt;/strong&gt;&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Thrombophlebitis&lt;/strong&gt;: Inflammation of the vein with the formation of a blood clot (thrombus).&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Tissue adhesive (TA)&lt;/strong&gt;: Medical-grade cyanoacrylate glue that can seal the insertion site and bond the catheter to the skin.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Transducer&lt;/strong&gt;: Device converting one form of energy to another.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Vascular access device (VAD)&lt;/strong&gt;: Device inserted into the vascular system, including veins, arteries, and bone marrow.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;(Source: INS 9th Edition 2024, Page 277)&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
